REFERENCES
1. EAU. Renal cell carcinoma. Available from: https://uroweb.org/guidelines/renal-cell-carcinoma. [Last accessed on 30 May 2024].
2. Mari A, Di Maida F, Tellini R, et al. Oncologic outcomes in patients treated with endoscopic robot assisted simple enucleation (ERASE) for renal cell carcinoma: results from a tertiary referral center. Eur J Surg Oncol 2019;45:1977-82.
3. Pecoraro A, Roussel E, Amparore D, et al. New-onset chronic kidney disease after surgery for localised renal masses in patients with two kidneys and preserved renal function: a contemporary multicentre study. Eur Urol Open Sci 2023;52:100-8.
4. Di Maida F, Campi R, Lane BR, et al. Predictors of positive surgical margins after robot-assisted partial nephrectomy for localized renal tumors: insights from a large multicenter international prospective observational project (the surface-intermediate-base margin score consortium). J Clin Med 2022;11:1765.
5. Grosso AA, Marìn DM, Di Maida F, et al. Robotic partial nephrectomy with en bloc removal of a renal vein thrombus for multiple cT3a renal cell carcinoma lesions. Eur Urol Open Sci 2022;44:33-6.
6. Mari A, Tellini R, Porpiglia F, et al. Perioperative and mid-term oncological and functional outcomes after partial nephrectomy for complex (PADUA score ≥10) renal tumors: a prospective multicenter observational study (the RECORD2 Project). Eur Urol Focus 2021;7:1371-9.
7. Tellini R, Antonelli A, Tardanico R, et al. Positive surgical margins predict progression-free survival after nephron-sparing surgery for renal cell carcinoma: results from a single center cohort of 459 cases with a minimum follow-up of 5 years. Clin Genitourin Cancer 2019;17:e26-31.
8. Carbonara U, Simone G, Capitanio U, et al. Robot-assisted partial nephrectomy: 7-year outcomes. Minerva Urol Nephrol 2021;73:540-3.
9. Antonelli A, Minervini A, Mari A, et al; RECORd Project-LUNA Foundation. TriMatch comparison of the efficacy of FloSeal versus TachoSil versus no hemostatic agents for partial nephrectomy: results from a large multicenter dataset. Int J Urol 2015;22:47-52.
10. Minervini A, Campi R, Kutikov A, et al. Histopathological validation of the surface-intermediate-base margin score for standardized reporting of resection technique during nephron sparing surgery. J Urol 2015;194:916-22.
11. Minervini A, Carini M, Uzzo RG, Campi R, Smaldone MC, Kutikov A. Standardized reporting of resection technique during nephron-sparing surgery: the surface-intermediate-base margin score. Eur Urol 2014;66:803-5.
12. Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol 2018;73:560-9.
13. Minervini A, Campi R, Sessa F, et al. Positive surgical margins and local recurrence after simple enucleation and standard partial nephrectomy for malignant renal tumors: systematic review of the literature and meta-analysis of prevalence. Minerva Urol Nefrol 2017;69:523-38.
14. Di Maida F, Campi R, Grosso AA, et al; Collaborators. Prognostic features of upstaged pT3a renal tumors with fat invasion after robot-assisted partial nephrectomy: is it time for a new subclassification? Eur J Surg Oncol 2023;49:862-7.
15. Campi R, Grosso AA, Lane BR, et al; SIB International Consortium. Impact of Trifecta definition on rates and predictors of “successful” robotic partial nephrectomy for localized renal masses: results from the Surface-Intermediate-Base Margin Score International Consortium. Minerva Urol Nephrol 2022;74:186-93.
16. Minervini A, Campi R, Lane BR, et al. Impact of resection technique on perioperative outcomes and surgical margins after partial nephrectomy for localized renal masses: a prospective multicenter study. J Urol 2020;203:496-504.
17. Porpiglia F, Bertolo R. Re: Positive surgical margins and local recurrence after simple enucleation and standard partial nephrectomy for malignant renal tumors: systematic review of the literature and meta-analysis of prevalence. Eur Urol 2018;73:480-1.
18. Di Maida F, Grosso AA, Sforza S, et al. Surgical management of synchronous, bilateral renal masses: a 1-decade referral center experience. Eur Urol Focus 2022;8:1309-17.
19. Grosso AA, Di Maida F, Tellini R, et al. Robot-assisted partial nephrectomy with 3D preoperative surgical planning: video presentation of the florentine experience. Int Braz J Urol 2021;47:1272-3.
20. Campi R, Di Maida F, Lane BR, et al; Members of the SIB International Consortium. Impact of surgical approach and resection technique on the risk of Trifecta Failure after partial nephrectomy for highly complex renal masses. Eur J Surg Oncol 2022;48:687-93.
21. Tuderti G, Mastroianni R, Anceschi U, et al. Assessing the trade-off between the safety and effectiveness of off-clamp robotic partial nephrectomy for renal masses with a high RENAL score: a propensity score-matched comparison of perioperative and functional outcomes in a multicenter analysis. Eur Urol Focus 2023;9:1037-43.
22. Bove P, Bertolo R, Sandri M, et al. Deviation from the protocol of a randomized clinical trial comparing on-clamp versus off-clamp laparoscopic partial nephrectomy (CLOCK II laparoscopic study): a real-life analysis. J Urol 2021;205:678-85.
23. Antonelli A, Cindolo L, Sandri M, et al; AGILE Group (Italian Group for Advanced Laparo-Endoscopic Surgery). Is off-clamp robot-assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial. BJU Int 2022;129:217-24.
24. Capitanio U, Larcher A, Cianflone F, et al. Hypertension and cardiovascular morbidity following surgery for kidney cancer. Eur Urol Oncol 2020;3:209-15.
25. Anceschi U, Brassetti A, Tuderti G, et al. Risk factors for progression of chronic kidney disease after robotic partial nephrectomy in elderly patients: results from a multi-institutional collaborative series. Minerva Urol Nephrol 2022;74:452-60.
26. Stencel MG, MacLeod L, Yabes JG, Yu M, Davies BJ, Jacobs BL. Partial nephrectomy drives the association between high-volume centers and decreased mortality: a surveillance, epidemiology, and end results-medicare analysis. Urology 2023;181:55-62.
27. Minervini A, Tuccio A, Masieri L, et al. Endoscopic robot-assisted simple enucleation (ERASE) for clinical T1 renal masses: description of the technique and early postoperative results. Surg Endosc 2015;29:1241-9.
28. Minervini A, Campi R, Di Maida F, et al. Tumor-parenchyma interface and long-term oncologic outcomes after robotic tumor enucleation for sporadic renal cell carcinoma. Urol Oncol 2018;36:527.e1-11.
29. Minervini A, Grosso AA, Di Maida F, et al. How far is too far? Exploring the indications for robotic partial nephrectomy in a highly complex kidney tumor. Int Braz J Urol 2020;46:871-2.
